These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 34221231)

  • 1. Patient Satisfaction with AbobotulinumtoxinA for Aesthetic Use in the Upper Face: A Systematic Literature Review and
    Smit R; Gubanova E; Kaufman J; Landau M; Molina B; Andriopoulos B; Maisonobe P; Prygova I; Redaelli A
    J Clin Aesthet Dermatol; 2021 Feb; 14(2):E69-E88. PubMed ID: 34221231
    [No Abstract]   [Full Text] [Related]  

  • 2. Onset and Duration of AbobotulinumtoxinA for Aesthetic Use in the Upper face: A Systematic Literature Review.
    Nestor M; Cohen JL; Landau M; Hilton S; Nikolis A; Haq S; Viel M; Andriopoulos B; Prygova I; Foster K; Redaelli A; Picaut P
    J Clin Aesthet Dermatol; 2020 Dec; 13(12):E56-E83. PubMed ID: 33488922
    [No Abstract]   [Full Text] [Related]  

  • 3. Efficacy and Safety of AbobotulinumtoxinA for the Treatment of Glabellar Lines in Chinese Patients: A Pivotal, Phase 3, Randomized, Double-Blind and Open-Label Phase Study.
    Wu Y; Fang F; Lai W; Li C; Li L; Liu Q; Lu J; Pang X; Sun J; Shi X; Picaut P; Prygova I; Andriopoulos B; Sun Q
    Aesthetic Plast Surg; 2023 Feb; 47(1):351-364. PubMed ID: 36536093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of Subject and Physician Satisfaction after Long-Term Treatment of Glabellar Lines with AbobotulinumtoxinA (Dysport
    Gubanova E; Haddad Tabet M; Bergerova Y; Moiseieva O; Chemeris A; Sanches E; Sharova A; Rodriguez Pose L; Raymond R; Prygova I; Carlisle I
    Aesthetic Plast Surg; 2018 Dec; 42(6):1672-1680. PubMed ID: 30120518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. International Consensus Recommendations on the Aesthetic Usage of Ready-to-Use AbobotulinumtoxinA (Alluzience).
    Ascher B; Rzany BJ; Kestemont P; Redaelli A; Hendrickx B; Iozzo I; Martschin C; Milotich A; Molina B; Cartier H; Picaut P; Prygova I
    Aesthet Surg J; 2024 Jan; 44(2):192-202. PubMed ID: 37490767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term Efficacy and Safety of Liquid AbobotulinumtoxinA Formulation for Moderate-to-Severe Glabellar Lines: A Phase III, Double-Blind, Randomized, Placebo-Controlled and Open-Label Study.
    Kestemont P; Hilton S; Andriopoulos B; Prygova I; Thompson C; Volteau M; Ascher B
    Aesthet Surg J; 2022 Feb; 42(3):301-313. PubMed ID: 34472596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AbobotulinumtoxinA Treatment of Glabellar Lines Using a New Reconstitution and Injection Volume: Randomized, Placebo-Controlled Data.
    Schlessinger J; Friedmann DP; Mayoral F; Mraz Robinson D; Glaser D; Wu D; Marcus K; Somenek M; Lin X
    J Drugs Dermatol; 2021 Sep; 20(9):988-995. PubMed ID: 34491022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pain Reduction With AbobotulinumtoxinA for the Treatment of Hallux Valgus in Adult Participants: Results of a Randomized and Placebo-Controlled Phase 2 Trial.
    Armstrong DG; DiDomenico LA; Baravarian B; Parekh SG; Volteau M; Silva R
    J Foot Ankle Surg; 2023; 62(2):244-253. PubMed ID: 36335048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient Perceived Benefit in Facial Aesthetic Procedures: FACE-Q as a Tool to Study Botulinum Toxin Injection Outcomes.
    Chang BL; Wilson AJ; Taglienti AJ; Chang CS; Folsom N; Percec I
    Aesthet Surg J; 2016 Jul; 36(7):810-20. PubMed ID: 26780945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Botulinum toxin: examining duration of effect in facial aesthetic applications.
    Flynn TC
    Am J Clin Dermatol; 2010; 11(3):183-99. PubMed ID: 20369902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of AbobotulinumtoxinA for Cosmetic Treatments in the Neck, and Middle and Lower Areas of the Face: A Systematic Review.
    Galadari H; Galadari I; Smit R; Prygova I; Redaelli A
    Toxins (Basel); 2021 Feb; 13(2):. PubMed ID: 33671800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Triple-Blind, Prospective, Internally Controlled Comparative Study Between AbobotulinumtoxinA and OnabotulinumtoxinA for the Treatment of Facial Rhytids.
    Kassir R; Kolluru A; Kassir M
    Dermatol Ther (Heidelb); 2013 Dec; 3(2):179-89. PubMed ID: 24318416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Remodeling of periorbital, temporal, glabellar, and crow's feet areas with hyaluronic acid and botulinum toxin.
    Beer KR; Julius H; Dunn M; Wilson F
    J Cosmet Dermatol; 2014 Jun; 13(2):143-50. PubMed ID: 24910278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Real-World, Retrospective, Multicenter, Observational Study on the Use of the First Liquid AbobotulinumtoxinA in Italy.
    Di Gregorio C; Tretti-Clementoni M; Belmontesi M; Romagnoli M; Innocenti A; Zanchi M; Leone L; Damiani G; Iozzo I
    Dermatol Ther (Heidelb); 2023 Jul; 13(7):1603-1610. PubMed ID: 37316750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematic review and cost-effectiveness analysis of the treatment of post-stroke spasticity with abobotulinumtoxinA compared to physiotherapy.
    Errea Rodríguez M; Fernández M; Del Llano J; Nuño-Solinís R
    Farm Hosp; 2023; 47(5):201-209. PubMed ID: 37244845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of the Efficacy and Durability of IncobotulinumtoxinA in the Treatment of the Upper Face in Adult Women.
    de Almeida AT; de Sanctis Pecora C; Marques ER; Contin L; de Almeida CT; da Cunha AL
    Dermatol Ther (Heidelb); 2024 Aug; 14(8):2093-2108. PubMed ID: 38954382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Real-world effectiveness of abobotulinumtoxinA (Dysport®) in adults with upper limb spasticity in routine clinical practice: an observational study.
    Sarzyńska-Długosz I; Szczepańska-Szerej A; Drużdż A; Łukomski T; Ochudło S; Fabian A; Sobolewski P; Mariańska K; Maciejewska J; Mulek E; Niedzielska A; Raymond R; Brzózka MM; Jessa-Jabłońska M
    Neurol Neurochir Pol; 2020; 54(1):90-99. PubMed ID: 31956971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of glabellar lines with botulinum toxin type A (Speywood Unit): a clinical overview.
    Rzany B; Ascher B; Monheit G
    J Eur Acad Dermatol Venereol; 2010 Jan; 24 Suppl 1():1-14. PubMed ID: 19930409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment approaches and outcomes associated with the use of abobotulinumtoxinA for the treatment of hyperhidrosis: A systematic review.
    Galadari H; Galadari I; Smit R; Prygova I; Redaelli A
    J Am Acad Dermatol; 2021 Nov; 85(5):1121-1129. PubMed ID: 32781184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systematic review and cost-effectiveness analysis of the treatment of post-stroke spasticity with abobotulinumtoxinA compared to physiotherapy.
    Errea Rodríguez M; Fernández M; Del Llano J; Nuño-Solinís R
    Farm Hosp; 2023; 47(5):T201-T209. PubMed ID: 37507277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.